Publisher: Cambridge University Press
E-ISSN: 1601-5215|6|1|12-20
ISSN: 0924-2708
Source: Acta Neuropsychiatrica, Vol.6, Iss.1, 1991-03, pp. : 12-20
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
An overview is given of some developments in the field of the molecular biological sciences with their impact on neuropsychiatry and psychopharmacology. Interference with the functioning of the cell will give some clues for the development of new psychotropic drugs. The genesis of disorders will be elucidated. This can lead to new methods of therapy. Moreover, the possibility to affect gene expression may offer opportunities for the development of new drugs. The existence and functioning of priones is explained. Interfering with neuroplastic principles may become an important method for the treatment of neurodegenerative diseases.
Related content
From genomics to proteomics: new directions in molecular neuropsychiatry
Acta Neuropsychiatrica, Vol. 15, Iss. 6, 2003-12 ,pp. :
Neuropsychiatry and neurophilosophy
Acta Neuropsychiatrica, Vol. 19, Iss. 3, 2007-06 ,pp. :
The cognitive neuropsychiatry of Parkinson's disease
By Brüne Martin
Cognitive Neuropsychiatry, Vol. 17, Iss. 5, 2012-09 ,pp. :
Decision making and neuropsychiatry
By Rahman S. J. Sahakia B. N. Cardinal R. Rogers R. Robbins T.
Trends in Cognitive Sciences, Vol. 5, Iss. 6, 2001-06 ,pp. :